Health Legislation

This Decree sets the operation modalities for some health competencies transferred by the State to the regions.

The decree creates the National Institute for Medical Assistance ("Institut National d'Assistance Médicale"), which is placed under the supervision of the Ministry of Public Health and the financial supervision of the Ministry of Finance. The Institute's main mission is to implement policies, strategies and reforms relating to the financing and delegated management of free health care for Niger's vulnerable populations by the State and local authorities.

The Order adopts the statutes of the National Institute for Medical Assistance ("Institut National d'Assistance Médicale"), which has as its main mission the implementation of policies, strategies and reforms relating to the financing and delegated management of free healthcare by the State and local authorities for the benefit of vulnerable populations in Niger.

The Decree sets out the statutes of the Nigerian Pharmaceutical Regulatory Agency.

The Decree adopts the National Strategy for University Health Coverage in Niger 2021-2030.

The Decree adopts the national pharmaceutical policy. This policy sets out and prioritizes the medium- and long-term goals set by the State for the pharmaceutical sector, and defines the main strategies for achieving them. It provides a framework within which pharmaceutical sector activities are coordinated. It covers both the public and private sectors, and involves all the main players in the pharmaceutical sector. It is an integral part of national health policy.

This decree establishes the National Institute for Medical Assistance (Institut National d'Assistance Médicale) whose mission is to implement the policies, strategies an reforms for finanicng and managing free healthcare services for vulnerable populations. It is under the ministry of health (technical supervision) and the Ministry of Finances (financial suppervision). The decree further addresses the mandate, structure and ressources of the Institute.

This Order provides for the creation of the Centre de Coordination des Opérations d'Urgences de Santé abbreviated to ‘CCOUSP’ (coordination center for health emergency operations).

The Decree sets out the terms of application of Law No. 2018-22 of April 27, 2018, determining the fundamental principles of Social Protection.

The decree creates a National Technical Committee responsible for the administration of the District Health Information System in Niger. Its mission is to ensure the administration and updating of the platform; to identify and deal with users' technical grievances and concerns, and to ensure the system's security, maintenance and capacity building.

The decree revises Niger's national list of essential medicines.

This decision by the minister of public health provides for pricing scheme for the treatment of severe malaria.

This decree establishes the criteria and the modalities to prove indigent status during a judicial process

The decree creates a multi-sectoral committee to combat counterfeiting and the illicit sale of medicines and other pharmaceutical products, reporting to Niger's Minister of Public Health.

This decree governs the organisation of the Ministry of Public Health and addresses among other things, the missions of the ministry (art. 1) and its structure (general structure is fleshed out under article 2).

The order creates a framework for reflection and exchange between players and partners in the implementation of health research, called the "Cadre de Concertation de la Recherche en Santé" (Health Research Consultation Framework), reporting to the Minister in charge of Public Health. Its mission is to promote exchanges and build the capacities of players involved in health research.

The decree establishes a Committee of Experts in charge of technical evaluation, whose mission is to carry out the technical evaluation of applications for registration of pharmaceutical products for human use. It also gives an opinion on the quality, safety and efficacy of pharmaceutical products for human use submitted for registration.

The decree creates the Commission Nationale du Médicament (CNM) for human use, whose mission is to validate the work of the Expert Committee responsible for the technical evaluation of applications for marketing authorization for pharmaceutical products for human use. It also gives a final opinion on marketing authorization applications; applications for renewal, extension of variation and transfer of marketing authorization; temporary suspension of marketing authorization; and proposals for definitive withdrawal of marketing authorization.

This decision by the minister of public health provides the prices and conditions of availability of rapid malaria diagnosis kits.

The decree revises Niger's national list of essential medicines from 2009